October 27, 2025 - 16:01

Anand Mahindra, the esteemed businessman, is recognized not only for his philanthropic spirit but also for his impressive fitness at the age of 70. His approach to health and wellness is refreshingly simple and relatable, emphasizing the importance of consistency and mindfulness.
In a recent post on social media, Mahindra opened up about his daily fitness regime. He humbly stated, "I’m no fitness guru but I rotate my weekly fitness routine between cardio-vascular activities like swimming and using ellipticals, muscle toning through weight workouts, and stretching practices such as yoga."
However, he highlighted that the cornerstone of his daily health routine is a 20-minute meditation session every morning. This blend of physical exercise and mental well-being illustrates Mahindra's holistic approach to fitness. His commitment to maintaining a balanced lifestyle serves as an inspiration to many, proving that age is just a number when it comes to health and vitality.
December 12, 2025 - 02:10
Senate Republicans Halt Efforts to Extend Health Insurance SubsidiesOn Thursday, Senate Republicans successfully blocked a motion aimed at advancing a Democratic proposal to prolong enhanced health insurance premium subsidies, which are set to expire at the end of...
December 11, 2025 - 08:03
WHO's New Pandemic Agreement: A Step Towards Equity in Global HealthOn May 20, 2025, the World Health Assembly reached a significant milestone by unanimously adopting the World Health Organization (WHO) Pandemic Agreement, an international treaty aimed at enhancing...
December 10, 2025 - 23:09
UAMS Expands Community Health Worker Training Initiative in ArkansasLITTLE ROCK — The University of Arkansas for Medical Sciences (UAMS) Institute for Community Health Innovation is set to enhance the community health worker (CHW) workforce in Arkansas with the...
December 10, 2025 - 04:47
FDA Initiates Safety Review of RSV Medications for Infants Amid Immunization ConcernsThe Food and Drug Administration (FDA) has announced a safety review of two medications designed to combat respiratory syncytial virus (RSV) in infants. This decision comes as scrutiny increases...